Alterity Therapeutics Announces 1-for-10 Reverse ADS Split (consolidation)
![]() |
MELBOURNE, Australia and SAN FRANCISCO, Jan. 6, 2023 /PRNewswire/ -- Alterity Therapeutics Limited ("Alterity" or the "Company") (ASX:ATH, NASDAQ:ATHE), a biotechnology company dedicated to developing disease modifying treatments for neurodegenerative diseases, today announced that its Board of Directors approved a ratio change of its American...
Read more: Alterity Therapeutics Announces 1-for-10 Reverse ADS Split (consolidation)